Survey of chronic pain in Chile – prevalence and treatment, impact

Por um escritor misterioso
Last updated 23 março 2025
Survey of chronic pain in Chile – prevalence and treatment, impact
Background and aims The prevalence of chronic non-cancer pain has not been specifically reported in Chile. Methods In order to assess its prevalence and impact, we designed a tool based on previously published survey studies. We analyzed a sample of 784 subjects to determine the prevalence of chronic non-cancer pain, with a maximum variability of 50%, a confidence interval (CI) of 95%, and an estimation error of 3.5%. Finally, a cross-sectional cell phone survey was conducted on a nationally representative probability sample of 865 subjects of over 18 years, in November 2013. The prevalence of chronic non-cancer pain was estimated by using expansion factors according to national projections by age group and gender, from the Chilean National Institute of Statistics for the year 2010. Results The estimated prevalence of chronic non-cancer pain was 32.1% (95% CI: 26.5–36.0). The respondents with chronic non-cancer pain presented the following results: 65.7% had moderate pain, and 20.8%, severe pain; 65.6% had somatic pain, 31.7% neuropathic pain, and 2.7% visceral pain. Approximately 70% reported they were receiving some kind of pharmacological treatment with certain frequency. In 64.9%, medication was prescribed by a physician. The prevalence of sick leave in workers was 30.22%, with a median duration of 14 days (interquartile range: 14; range: 1–60). Conclusions Chronic non-oncological pain occurs in 32% of Chilean adults. These figures provide the first measurement of chronic non-cancer pain in the Chilean population. Implications Chronic non-oncological pain impact as a public health problem is revealed, given the high prevalence found, and the elevated private and social costs involved.
Survey of chronic pain in Chile – prevalence and treatment, impact
Frontiers Publishing Partnerships Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Survey of chronic pain in Chile – prevalence and treatment, impact
Cost analysis of chronic pain due to musculoskeletal disorders in Chile
Survey of chronic pain in Chile – prevalence and treatment, impact
Visceral Pain Treatment Market - Region and Forecast (2023-2029)
Survey of chronic pain in Chile – prevalence and treatment, impact
JPM, Free Full-Text
Survey of chronic pain in Chile – prevalence and treatment, impact
PDF) Survey of chronic pain in Chile - Prevalence and treatment, impact on mood, daily activities and quality of life
Survey of chronic pain in Chile – prevalence and treatment, impact
Frontiers Co-designing a Canadian adaptation of a lifestyle-oriented intervention aimed to improve daily functioning of individuals living with chronic pain: a multi-method study protocol of REVEAL(OT) Canada
Survey of chronic pain in Chile – prevalence and treatment, impact
Maximizing treatment efficacy through patient stratification in neuropathic pain trials
Survey of chronic pain in Chile – prevalence and treatment, impact
The collateral damage of endometriosis: Increased risk of cancer, chronic pain and infertility, Health
Survey of chronic pain in Chile – prevalence and treatment, impact
Short-form McGill Pain Questionnaire - Physiopedia
Survey of chronic pain in Chile – prevalence and treatment, impact
Survey of chronic pain in Chile – prevalence and treatment, impact on mood, daily activities and quality of life
Survey of chronic pain in Chile – prevalence and treatment, impact
Gout Market Size, Share Forecast 2032

© 2014-2025 progresstn.com. All rights reserved.